CRISPR Technology: Global Markets

Report Code: HLC258C

Publish Date: Oct 2024

Publisher: BCC Publishing

Category: Health Maintenance

Download Report Overview

Single User License: $4650

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Report Includes

  • 32 data tables and 61 additional tables
  • An analysis of the global market for CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology
  • Analyses of the global market trends, with data from 2021-2022, estimates for 2023, forecast for 2024, and projected CAGRs through 2029
  • Discussion of the market potential for CRISPR technology
  • Estimate of the market size and a revenue forecast for the global CRISPR technology market, and a corresponding market share analysis by application, end user, and region
  • Discussion of the major market dynamics, regulations, industry challenges, and macroeconomic factors that will affect the demand for CRISPR technology market over the next five years
  • A look at the recent breakthrough in CRISPR-Cas9 genome editing technology, and how it has propelled the rapid growth in genetic engineering and advanced pharmacological research
  • A comparative study on CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion on its higher adaptability over other nucleases
  • Review of the patent filings and research publications for innovations in the CRISPR-Cas9 genome editing technology
  • A discussion on ESG challenges and ESG practices of the industry participants
  • A look at the proprietary technologies and strategic alliances of the companies best positioned in the CRISPR market
  • Analysis of the industry structure, competitive landscape, clinical trials, ongoing research activities, and the impact of COVID-19
  • Company profiles of the major players, including Merck KGaA, Thermo Fisher Scientific, Beam Therapeutics, CRISPR Therapeutics and Danaher Corp.

Report Scope

This report on CRISPR technology provides market projections for 2029 and analyzes the market for CRISPR technology by application and end user. Applications covered include drug development, agriculture, diagnostics and others. End users include biotechnology and pharmaceutical companies, academics and government research institutes, and contract research organizations.

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2024-2029
Base year market size $3.4 Billion
Market size forecast $7.5 Billion
Growth rate CAGR of 14.4% from 2024 to 2029
Units considered $ Millions
Segments covered By Application, End User, and Region
Regions covered North America, Europe, Asia-Pacific and the Rest of the World (RoW)
Countries covered U.S., Canada, Germany, United Kingdom, France, Japan, China and India
Key Market Drivers
  • Rising incidence of chronic diseases.
  • High prevalence of genetic disorders.
  • Government and private funding.
Companies studied
AGILENT TECHNOLOGIES INC.BEAM THERAPEUTICS
CARIBOU BIOSCIENCES INC.CRISPR THERAPEUTICS
DANAHER CORP.EDITAS MEDICINE
GENSCRIPTINTELLIA THERAPEUTICS INC.
LONZAMERCK KGAA
THERMO FISHER SCIENTIFIC INC.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global CRISPR technology market is expected to grow at a compound annual growth rate (CAGR) of 14.4% to reach $7.5 billion by 2029 from $3.8 billion in 2024.
The CRISPR technology market is driven by the rising incidence of chronic diseases, the high prevalence of genetic disorders, and growing government and private funding.
The CRISPR technology market is segmented based on application, end user, and region.
The drug development segment will dominate the market by the end of 2029.
North America holds the highest share of the market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: CRISPR Technology: Global Markets122Free
Chapter- 1: Executive Summary3Free
Chapter- 2: Market Overview17Free
Chapter- 3: Market Dynamics9Free
Chapter- 4: Emerging Technologies and Developments9Free
Chapter- 5: Market Segmentation Analysis32Free
Chapter- 6: Competitive Intelligence5Free
Chapter- 7: Sustainability in CRISPR Technology: An ESG Perspective6Free
Chapter- 8: Appendix41Free
Published - Feb-2023| Analyst - BCC Publishing| Code - HLC258B

Report Highlights

The global CRISPR Technology market reached $3.3 billion in 2022 and should reach $9.2 billion by 2027, with a compound annual growth rate (CAGR) of 22.3% during the forecast period of 2022-2027.

Report Includes

  • 17 data tables and 37 additional tables
  • An up-to-date overview and analysis of the global market for CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology
  • Analyses of the global market trends, with historic revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the market potential for CRISPR technology, industry growth drivers, and areas of focus to forecast this market into various segments and sub-segments
  • Estimation of the actual market size and revenue forecast for the global CRISPR technology market in USD million terms, and corresponding market share analysis by application, end user, and region
  • Discussion of the major market dynamics, key shifts and regulations, industry specific challenges, and macroeconomic factors affecting the demand for CRISPR technology market over the coming years (2022-2027)
  • Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances, or other advantages
  • A look at the recent technical breakthrough on the use of CRISPR-Cas9 genome editing technology, and how it has propelled the rapid growth in genetic engineering and advanced pharmacological research
  • Comparative study on CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion on its higher adaptability over other nucleases
  • Review of the patent filings and research publications for innovations in the CRISPR-Cas9 genome editing technology
  • Insight into recent industry structure for CRISPR-Cas9 genome editing technology, competitive environment, clinical trials, ongoing research activities, and the COVID-19 impact on the marketplace
  • Company profiles of major players within the industry, including CRISPR Therapeutics AG, GenScript, Lonza Group Ltd, PerkinElmer and Thermo Fisher Scientific Inc.
Published - Jun-2020| Analyst - Vijay Laxmi| Code - HLC258A

Report Highlights

The global market for CRISPR technology should grow from $75.0 billion in 2018 to $218.9 billion by 2023, at a compound annual growth rate (CAGR) of 23.9% for the period of 2018-2023.

Report Includes

  • 45 data tables and 35 additional tables
  • An overview of global CRISPR market, discussion on CRISPR interference technique and its potential application in alteration of germline in animal, human and other organisms
  • Analyses of global market trends, with market data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Explanation of the major drivers and regional dynamics of the global CRISPR market and evaluation of its current market size, and market forecast
  • Comparative study on CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion on its higher adaptability over other nucleases
  • Information on congenital anomalies, its prevalence, causes and its relation to mortality rate
  • Knowledge about Cell Line Engineering, CRISPR Plasmid, Genetic Engineering, GRNA Database/Gene Library and Human Stem Cells
  • Insights into regulatory framework and investment analysis
  • Market share analysis of the leading suppliers of the industry and their detailed company profiles, including Caribou Biosciences, Genscript, Integrated DNA Technologies, Intellia Therapeutics Inc., Precision Biosciences, Sangamo Therapeutics Inc., and Thermo Fisher Scientific

Related Reports

Induced Pluripotent Stem Cells: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO135F

The global market for induced pluripotent stem cells (iPSCs) is expected to grow from $3.4 billion in 2023 to reach $5.2 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.1% from 2023 to 2028.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Agricultural Biotechnology: Emerging Technologies and Global Markets

Published - Nov 2023 | Publisher - BCC Publishing | Code - BIO100E

The global market for agricultural biotechnology is estimated to increase from $79.9 billion in 2023 to reach $119.6 billion by 2028, at a compound annual growth rate (CAGR) of 8.4% from 2023 through 2028.

Genome Editing: Technologies and Global Markets

Published - Jun 2022 | Publisher - BCC Publishing | Code - BIO146C

The global genome editing market should reach $12.8 billion by 2027 from $4.3 billion in 2022 at a compound annual growth rate (CAGR) of 24.7% for the forecast period of 2022 to 2027.

Recent Reports

Surgical Equipment: Technologies and Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - HLC154C

The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.

Conventional and Alternative Pain Treatment Markets

Published - Nov 2024 | Publisher - Partha Sarathi Das | Code - HLC266B

The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
CRISPR Technology: Global Markets
Sample Report